Annual Operating Profit
$21.63 M
+$61.00 M+154.95%
December 31, 2023
Summary
- As of February 20, 2025, ADMA annual operating income is $21.63 million, with the most recent change of +$61.00 million (+154.95%) on December 31, 2023.
- During the last 3 years, ADMA annual operating profit has risen by +$86.55 million (+133.32%).
- ADMA annual operating profit is now at all-time high.
Performance
ADMA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$39.64 M
+$437.00 K+1.11%
September 30, 2024
Summary
- As of February 20, 2025, ADMA quarterly operating income is $39.64 million, with the most recent change of +$437.00 thousand (+1.11%) on September 30, 2024.
- Over the past year, ADMA quarterly operating profit has stayed the same.
- ADMA quarterly operating profit is now at all-time high.
Performance
ADMA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$114.89 M
+$30.95 M+36.88%
September 30, 2024
Summary
- As of February 20, 2025, ADMA TTM operating income is $114.89 million, with the most recent change of +$30.95 million (+36.88%) on September 30, 2024.
- Over the past year, ADMA TTM operating profit has stayed the same.
- ADMA TTM operating profit is now at all-time high.
Performance
ADMA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ADMA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +154.9% | 0.0% | 0.0% |
| 3 y3 years | +133.3% | +754.3% | +391.9% |
| 5 y5 years | +135.9% | +754.3% | +391.9% |
ADMA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.1% | at high | +367.6% | at high | +296.8% |
| 5 y | 5-year | at high | +133.3% | at high | +330.2% | at high | +277.0% |
| alltime | all time | at high | +133.3% | at high | +330.2% | at high | +277.0% |
ADMA Biologics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $39.64 M(+1.1%) | $114.89 M(+36.9%) |
| Jun 2024 | - | $39.20 M(+79.6%) | $83.94 M(+89.6%) |
| Mar 2024 | - | $21.82 M(+53.3%) | $44.27 M(+104.6%) |
| Dec 2023 | $21.63 M(-155.0%) | $14.23 M(+63.9%) | $21.63 M(+1513.7%) |
| Sep 2023 | - | $8.69 M(-1936.2%) | $1.34 M(-108.0%) |
| Jun 2023 | - | -$473.00 K(-41.8%) | -$16.66 M(-34.3%) |
| Mar 2023 | - | -$813.00 K(-86.6%) | -$25.36 M(-35.6%) |
| Dec 2022 | -$39.37 M(-32.6%) | -$6.06 M(-35.0%) | -$39.37 M(-15.3%) |
| Sep 2022 | - | -$9.32 M(+1.5%) | -$46.50 M(-9.9%) |
| Jun 2022 | - | -$9.17 M(-38.1%) | -$51.62 M(-11.0%) |
| Mar 2022 | - | -$14.82 M(+12.3%) | -$58.02 M(-0.6%) |
| Dec 2021 | -$58.37 M(-10.1%) | -$13.19 M(-8.6%) | -$58.37 M(-6.5%) |
| Sep 2021 | - | -$14.44 M(-7.3%) | -$62.40 M(+1.0%) |
| Jun 2021 | - | -$15.58 M(+2.7%) | -$61.77 M(-2.4%) |
| Mar 2021 | - | -$15.16 M(-11.9%) | -$63.31 M(-2.5%) |
| Dec 2020 | -$64.91 M(+56.7%) | -$17.22 M(+24.8%) | -$64.91 M(+16.9%) |
| Sep 2020 | - | -$13.80 M(-19.4%) | -$55.52 M(+9.4%) |
| Jun 2020 | - | -$17.12 M(+2.1%) | -$50.77 M(+12.9%) |
| Mar 2020 | - | -$16.77 M(+114.3%) | -$44.99 M(+8.6%) |
| Dec 2019 | -$41.42 M(-31.3%) | -$7.83 M(-13.5%) | -$41.42 M(-17.4%) |
| Sep 2019 | - | -$9.05 M(-20.2%) | -$50.15 M(-8.6%) |
| Jun 2019 | - | -$11.34 M(-14.2%) | -$54.89 M(-3.6%) |
| Mar 2019 | - | -$13.21 M(-20.2%) | -$56.96 M(-5.5%) |
| Dec 2018 | -$60.29 M(+56.7%) | -$16.55 M(+20.0%) | -$60.29 M(+12.8%) |
| Sep 2018 | - | -$13.79 M(+2.8%) | -$53.44 M(-1.2%) |
| Jun 2018 | - | -$13.42 M(-18.8%) | -$54.08 M(+10.2%) |
| Mar 2018 | - | -$16.53 M(+70.5%) | -$49.06 M(+27.5%) |
| Dec 2017 | -$38.46 M | -$9.70 M(-32.8%) | -$38.46 M(+17.6%) |
| Sep 2017 | - | -$14.43 M(+71.7%) | -$32.71 M(+48.6%) |
| Jun 2017 | - | -$8.40 M(+41.5%) | -$22.02 M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$5.94 M(+50.5%) | -$19.11 M(+10.3%) |
| Dec 2016 | -$17.33 M(+11.7%) | -$3.94 M(+5.5%) | -$17.33 M(-1.1%) |
| Sep 2016 | - | -$3.74 M(-31.9%) | -$17.52 M(-5.0%) |
| Jun 2016 | - | -$5.49 M(+32.0%) | -$18.44 M(+12.0%) |
| Mar 2016 | - | -$4.16 M(+0.7%) | -$16.47 M(+6.2%) |
| Dec 2015 | -$15.51 M(-3.2%) | -$4.13 M(-11.4%) | -$15.51 M(+2.8%) |
| Sep 2015 | - | -$4.66 M(+32.6%) | -$15.09 M(+12.1%) |
| Jun 2015 | - | -$3.52 M(+9.8%) | -$13.47 M(-0.5%) |
| Mar 2015 | - | -$3.20 M(-13.7%) | -$13.54 M(-15.5%) |
| Dec 2014 | -$16.02 M(+6.5%) | -$3.71 M(+22.1%) | -$16.02 M(-4.8%) |
| Sep 2014 | - | -$3.04 M(-15.3%) | -$16.83 M(+3.1%) |
| Jun 2014 | - | -$3.59 M(-36.9%) | -$16.32 M(-7.1%) |
| Mar 2014 | - | -$5.68 M(+25.8%) | -$17.58 M(+16.8%) |
| Dec 2013 | -$15.04 M(+90.2%) | -$4.52 M(+78.5%) | -$15.04 M(+6.7%) |
| Sep 2013 | - | -$2.53 M(-47.7%) | -$14.09 M(-1.6%) |
| Jun 2013 | - | -$4.84 M(+53.7%) | -$14.32 M(+39.0%) |
| Mar 2013 | - | -$3.15 M(-11.7%) | -$10.31 M(+30.3%) |
| Dec 2012 | -$7.91 M(>+9900.0%) | -$3.57 M(+29.3%) | -$7.91 M(+81.9%) |
| Sep 2012 | - | -$2.76 M(+233.5%) | -$4.35 M(+172.9%) |
| Jun 2012 | - | -$827.40 K(+10.0%) | -$1.59 M(+105.0%) |
| Mar 2012 | - | -$752.00 K(+8960.2%) | -$777.20 K(+2482.1%) |
| Dec 2011 | - | -$8300.00(+59.6%) | -$30.10 K(+11.5%) |
| Sep 2011 | - | -$5200.00(-55.6%) | -$27.00 K(+2.3%) |
| Jun 2011 | -$26.50 K(+29.3%) | -$11.70 K(+138.8%) | -$26.40 K(+18.4%) |
| Mar 2011 | - | -$4900.00(-5.8%) | -$22.30 K(+0.5%) |
| Dec 2010 | - | -$5200.00(+13.0%) | -$22.20 K(+4.2%) |
| Sep 2010 | - | -$4600.00(-39.5%) | -$21.30 K(+27.5%) |
| Jun 2010 | - | -$7600.00(+58.3%) | -$16.70 K(+83.5%) |
| Jun 2010 | -$20.50 K | - | - |
| Mar 2010 | - | -$4800.00(+11.6%) | -$9100.00(+111.6%) |
| Dec 2009 | - | -$4300.00 | -$4300.00 |
FAQ
- What is ADMA Biologics annual operating income?
- What is the all time high annual operating profit for ADMA Biologics?
- What is ADMA Biologics annual operating profit year-on-year change?
- What is ADMA Biologics quarterly operating income?
- What is the all time high quarterly operating profit for ADMA Biologics?
- What is ADMA Biologics quarterly operating profit year-on-year change?
- What is ADMA Biologics TTM operating income?
- What is the all time high TTM operating profit for ADMA Biologics?
- What is ADMA Biologics TTM operating profit year-on-year change?
What is ADMA Biologics annual operating income?
The current annual operating profit of ADMA is $21.63 M
What is the all time high annual operating profit for ADMA Biologics?
ADMA Biologics all-time high annual operating income is $21.63 M
What is ADMA Biologics annual operating profit year-on-year change?
Over the past year, ADMA annual operating income has changed by +$61.00 M (+154.95%)
What is ADMA Biologics quarterly operating income?
The current quarterly operating profit of ADMA is $39.64 M
What is the all time high quarterly operating profit for ADMA Biologics?
ADMA Biologics all-time high quarterly operating income is $39.64 M
What is ADMA Biologics quarterly operating profit year-on-year change?
Over the past year, ADMA quarterly operating income has changed by $0.00 (0.00%)
What is ADMA Biologics TTM operating income?
The current TTM operating profit of ADMA is $114.89 M
What is the all time high TTM operating profit for ADMA Biologics?
ADMA Biologics all-time high TTM operating income is $114.89 M
What is ADMA Biologics TTM operating profit year-on-year change?
Over the past year, ADMA TTM operating income has changed by $0.00 (0.00%)